Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-012273

Options or other derivatives

  • Chief Commercial Officer acquired 305,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kirby Daniel Gordon Chief Commercial Officer 2025-02-10 Grant or award · Stock Options (Right to Buy) +35,000 35,000 D
Kirby Daniel Gordon Chief Commercial Officer 2025-02-10 Grant or award · Restricted Stock Units +120,000 120,000 D
Kirby Daniel Gordon Chief Commercial Officer 2025-02-10 Grant or award · Performance Stock Units +150,000 150,000 D
Loading xslF345X05/tm256127d2_4seq1.xml…